Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Sight Sciences Inc - SIC # 3841 - SURGICAL AND MEDICAL INSTRUMENTS AND APPARATUS
Ticker
Exchange
SIC #
Website
Latest Ticker
SGHT
Nasdaq
3841
https://www.sightsciences.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Sight Sciences Inc
Sight Sciences Two Year Multicenter Study Results Show Sustained Reductions in Both Intraocular Pressure (IOP) and Glaucoma Medication Use in Mild-Moderate Primary Open Angle Glaucoma Patients Treated with a Procedure Enabled with the OMNI® Surgical System Technology
- May 23rd, 2023 12:30 pm
How Much Upside is Left in Sight Sciences, Inc. (SGHT)? Wall Street Analysts Think 38.78%
- May 9th, 2023 1:55 pm
Sight Sciences Announces 12-month Results from the First Minimally Invasive Glaucoma Surgery (MIGS) Comparative Analysis of Real-World Data (RWD) from the American Academy of Ophthalmology IRIS® Registry
- May 6th, 2023 3:30 pm
Sight Sciences, Inc. (SGHT) Reports Q1 Loss, Misses Revenue Estimates
- May 4th, 2023 10:45 pm
Sight Sciences Reports First Quarter 2023 Financial Results and Reaffirms Guidance for Full Year 2023
- May 4th, 2023 8:05 pm
Sight Sciences' Glaucoma and Dry Eye Technologies to be Featured in Multiple Clinical Presentations at the 2023 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting
- May 1st, 2023 8:05 pm
Sight Sciences to Present at the Upcoming Bank of America Securities 2023 Health Care Conference
- Apr 26th, 2023 8:05 pm
Sight Sciences to Report First Quarter 2023 Financial Results on May 4, 2023
- Apr 20th, 2023 8:05 pm
Why Investors Shouldn't Be Surprised By Sight Sciences, Inc.'s (NASDAQ:SGHT) P/S
- Apr 19th, 2023 5:57 pm
Sight Sciences to Host Surgical Glaucoma Investor Symposium on Friday, May 5, 2023
- Apr 13th, 2023 8:05 pm
Strength Seen in Sight Sciences, Inc. (SGHT): Can Its 5.6% Jump Turn into More Strength?
- Apr 11th, 2023 9:22 am
Sight Sciences Appoints Ali Bauerlein as Chief Financial Officer
- Apr 3rd, 2023 8:05 pm
Sight Sciences Defeats Invalidity Challenges Filed By Alcon and Ivantis In The U.S. Patent Office
- Mar 30th, 2023 12:00 pm
Owning 30% shares,institutional owners seem interested in Sight Sciences, Inc. (NASDAQ:SGHT),
- Mar 23rd, 2023 3:25 pm
Sight Sciences, Inc. (NASDAQ:SGHT) Q4 2022 Earnings Call Transcript
- Mar 14th, 2023 3:22 pm
Sight Sciences, Inc. (SGHT) Reports Q4 Loss, Tops Revenue Estimates
- Mar 13th, 2023 9:25 pm
Sight Sciences Reports Fourth Quarter and Full Year 2022 Financial Results
- Mar 13th, 2023 8:05 pm
Sight Sciences Launches the Ergo-Series of the OMNI® Surgical System
- Mar 9th, 2023 1:30 pm
Sight Sciences to Report Fourth Quarter and Full Year 2022 Financial Results on March 13, 2023
- Feb 23rd, 2023 9:05 pm
Sight Sciences to Present at the Upcoming Citi 2023 Healthcare Services, Medtech, Tools & HCIT Conference
- Feb 22nd, 2023 9:05 pm
Scroll